Find activities

96 results

  • MSAC Consultation Survey - Application 1659.1

    MSAC application 1659.1 Catheter-based renal denervation for uncontrolled elevated systolic blood pressure. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened today

  • MSAC Consultation Survey - Application 1782.1

    MSAC application 1782.1 Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with estrogen receptor (ER)-positive, HER2-negative, locally advanced or metastatic breast cancer, to determine eligibility for treatment with PBS subsidised elacestrant. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Opened today

  • MSAC Consultation Survey - Application 1795

    MSAC application 1795 Positron emission tomography / computed tomography (PET/CT) dopaminergic imaging for evaluating Parkinsonism. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the... More
    Opened today

  • MSAC Consultation Survey - Application 1793

    MSAC application 1793 Diagnostic genomic testing for fetal anomalies Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by providing MSAC... More
    Opened today

  • MSAC Consultation Survey - Application 1786 - resubmission

    A further period of consultation is open on application 1786 – FreeStyle Libre 2 continuous glucose monitoring (CGM) System for people with insulin-dependent type 2 diabetes, gestational diabetes and type 3c diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. ... More
    Opened today

  • MSAC Consultation Survey - Application 1812

    MSAC application 1812 Transcatheter Edge-To-Edge Repair (TEER) for the treatment of severe tricuspid regurgitation (TR) using the TriClip device. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology... More
    Opened today

  • MSAC Consultation Survey - Application 1785 - resubmission

    A further period of consultation is open on application 1785 – Dexcom ONE+ Continuous Glucose Monitoring (CGM) System for people with insulin-dependent type 2 diabetes, for consideration by the Medical Services Advisory Committee (MSAC) and its Evaluation Subcommittee (ESC). Consultation input helps MSAC and its subcommittees to better understand how a proposed health service or technology fits in the Australian health care environment. MSAC previously considered application... More
    Opened today

  • MSAC Consultation Survey - Application 1817

    MSAC application 1817 Xeomin (incobotulinumtoxinA) injection codes for lower limb spasticity following an acute event. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health... More
    Closed 20 February 2026

  • MSAC Consultation Survey - Application 1790

    MSAC application 1790 POLE genotyping for the molecular classification of endometrial cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It... More
    Closed 13 February 2026

  • MSAC Consultation Survey - Application 1796

    MSAC application 1796 ADAMTS13 testing for the diagnosis of thrombotic thrombocytopenic purpura (TTP). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closed 13 February 2026

  • MSAC Consultation Survey - Application 1804

    MSAC application 1804 - Genetic testing to detect RET variants in patients with medullary thyroid cancer to determine eligibility for PBS subsidised selpercatinib treatment. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed... More
    Closed 13 February 2026

  • MSAC Consultation Survey - Application 1805

    MSAC application 1805 - Concizumab for routine prophylaxis to prevent bleeding in patients with haemophilia B. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closed 13 February 2026

  • MSAC Consultation Survey - Application 1806

    MSAC application 1806 - Marstacimab for routine prophylaxis to prevent bleeding in patients with haemophilia. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closed 13 February 2026

  • MSAC Consultation Survey - Application 1657.1

    MSAC application 1657.1 Rhenium-188 brachytherapy for non-melanoma skin cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does this by... More
    Closed 13 February 2026

  • MSAC Consultation Survey - Application 1816

    MSAC application 1816 Genetic testing to detect estrogen receptor 1 (ESR1) variants in patients with hormone receptor (HR)-positive, HER-2 negative, locally advanced or metastatic breast cancer to determine eligibility for treatment with PBS subsidised camizestrant. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). ... More
    Opened 30 January 2026

  • MSAC Consultation Survey - Application 1815

    MSAC application 1815 Computed tomography (CT) of the coronary arteries to determine coronary artery calcium score. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health... More
    Opened 30 January 2026

  • MSAC Consultation Survey - Application 1814

    MSAC application 1814 Bronchoscopic lung volume reduction with endobronchial valves for the treatment of severe emphysema. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian... More
    Opened 30 January 2026

  • MSAC Consultation Survey - Application 1813

    MSAC application 1813 Detection of measurable residual disease in patients with acute myeloid leukaemia. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Opened 30 January 2026

  • Public consultation on items to be considered by the PBAC (March 2026)

    Consultation has opened for the March 2026 Pharmaceutical Benefits Advisory Committee (PBAC) agenda. The PBAC welcomes input from patients, carers, health professionals, consumer groups or organisations and members of the public on medicines and vaccines submitted for PBAC consideration. The PBAC considers these public consultation inputs when considering the clinical and economic evidence presented by the applicant. Information provided by consumers helps the committee... More
    Closed 21 January 2026

  • REGISTER for "Enhancing HTA - 2025 Reflections" Consumer Webinar, 3 December 2025

    The HTA Consumer Consultative Committee (CCC) invites representatives of health consumer organisations to a free webinar. "Enhancing HTA - 2025 Reflections" 11:00am - 12:30pm (AEDT), Wednesday 3 December 2025 About the webinar: Hosted by the Chair of the HTA-CCC, Jo Watson, this 90-minute webinar will reflect on highlights of consumer sector activities in HTA during 2025. It will also look towards consumer engagement opportunities in 2026. Speakers will include... More
    Closed 1 December 2025

  • MSAC Consultation Survey - Application 1811

    MSAC application 1811 Testing for MET overexpression and amplification in patients with locally advanced or metastatic non-small cell lung cancer to determine eligibility for treatment with PBS subsidised savolitinib in combination with osimertinib. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input ... More
    Closed 7 November 2025

  • MSAC Consultation Survey - Application 1809

    MSAC application 1809 Genomic testing in cancer of unknown primary (CUP) and diagnostically challenging cancers. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closed 7 November 2025

  • MSAC Consultation Survey - Application 1810

    MSAC application 1810 Genomic testing for the diagnosis of primary immunodeficiency (PID). Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care environment. It does... More
    Closed 7 November 2025

  • MSAC Consultation Survey - Application 1799

    MSAC application 1799 - Transcatheter tricuspid valve replacement in patients with severe, symptomatic tricuspid regurgitation despite optimal medical therapy. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service... More
    Closed 10 October 2025

  • MSAC Consultation Survey - Application 1797

    MSAC application 1797 - Vibration-Controlled Transient Elastography (VCTE™) for identifying advanced fibrosis in patients with metabolic dysfunction-associated fatty liver disease. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a... More
    Closed 10 October 2025

  • MSAC Consultation Survey - Application 1798

    MSAC application 1798 - Liquid biopsy genetic testing in patients with non-small cell lung cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better understand how a proposed health service or technology fits in the Australian health care ... More
    Closed 10 October 2025

  • MSAC Consultation Survey - Application 1752

    MSAC application 1752 - Anal human papillomavirus (HPV) and cytology testing in high-risk populations to determine access to high-resolution anoscopy and ablative treatment to prevent anal cancer. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... More
    Closed 10 October 2025

  • MSAC Consultation Survey - Application 1779.1

    MSAC application 1779.1 Testing of tumour tissue to detect FGFR2 fusions or rearrangements in people with cholangiocarcinoma, to determine eligibility for treatment with PBS subsidised futibatinib. Consultation is open on applications for consideration by the Medical Services Advisory Committee (MSAC) and its sub-committees — the PICO Advisory Sub-Committee (PASC) and Evaluation Sub-Committee (ESC). Consultation input helps MSAC and its sub-committees to better... More
    Closed 10 October 2025

  • HTA Review Implementation Advisory Group Draft Roadmap - Webinar Registration

    The Health Technology Assessment Review Implementation Advisory Group (the IAG) is now developing its advice on a draft implementation roadmap for government consideration and invites you to attend a webinar hosted by the IAG Chair, Professor Andrew Wilson and contribute to this process. The session will provide insights into the IAG’s development of the roadmap and the proposed approach to the prioritisation of actions. Following the webinar, a short survey will be sent to... More
    Closed 3 October 2025

  • REGISTER for "Enhancing HTA Feedback - From HTA Inputs to Outcomes" Consumer Webinar, 1 October 2025

    The HTA Consumer Consultative Committee (CCC) invites representatives of health consumer organisations to a free webinar. “Enhancing HTA Feedback - From HTA Inputs to Outcomes” HTA inputs/outcomes in relation to the Pharmaceutical Benefits Advisory Committee (PBAC) and the Medical Services Advisory Committee (MSAC) 11:00am – 12:30pm AEST, Wednesday 1 October 2025 About the webinar: HTA Committees seek input from... More
    Closed 26 September 2025
96 results. Page 1 of 4